News
ECT more effective for psychotic vs. nonpsychotic depression?
In one study, response rates to ECT were significantly higher for the patients with psychotic depression than for those with nonpsychotic...
News
Device improves physical exam completion rates in serious mental illness
Use of the Afinion 2 device (Abbott) was associated with a doubling of completed physical health checkups.
News
Psychiatry trainees subjected to high levels of physical, sexual, verbal abuse from patients
"The extent of violence ... calls for the implementation of effective training, prevention, and intervention measures," said Dr. Victor Pereira-...
News
Caution urged for antidepressant use in bipolar depression
Isabella Pacchiarotti, MD, PhD, argued against the use of antidepressants in treating bipolar; Guy Goodwin, PhD, took the ‘pro’ stance.
News
Family environment important in early psychosis outcomes
“Having family involvement in care is one of the most robust predictors that young people with psychosis will remain engaged in mental health...
News
Drug-drug interactions to avoid in patients with GI cancer
One combination to avoid is proton pump inhibitors and chemotherapy regimens containing capecitabine.
News
Community programs improve psychosis outcomes
In one study, the team was able to nearly halve the time from diagnosis to initiation of antipsychotic treatment.
News
Potential new biomarker for psychosis severity
The results "highlight ACE as a promising peripheral biomarker to identify patients at risk of treatment resistance to antipsychotics," the...
News
Injectable vs. oral antipsychotics: Which do patients prefer?
The highest preference for LAIs was in Europe, at 88%, versus 59.1% in the United States and 70.7% in the rest of the world.
News
Cortisol levels on COVID-19 admission may be a marker of severity
Those with COVID-19 do appear to mount a stress response to the infection, and cortisol levels on admission to hospital can help determine the...
News
What’s pushing cannabis use in first-episode psychosis?
It might be beneficial to identify the specific cause of the psychological discomfort driving cannabis use, such as depression, said Dr. Edoardo...
News
Three years of imatinib may halve death rate in GIST
Receiving imatinib for 3 years rather than 1 year improved overall survival by 50% and recurrence-free survival by 30%.